During the past decade, a variety of instrument-assisted bacterial identification and antimicrobial susceptibility test systems have been developed which permit provision of test results in a matter of hours rather than days, as has been the case with traditional overnight procedures.
These newer rapid techniques are much more expensive than older methods.
It has been presumed but not proven that the clinical benefits of rapid testing to patients with infection offset the added cost.
The intent of this study was to objectively define the clinical impact of rapid bacterial identification and antimicrobial susceptibility testing.
Mots-clés Pascal : Test sensibilité médicamenteuse, Identification, Technique rapide, Infection, Hospitalisation, Soin, Coût, Aspect économique, Mortalité
Mots-clés Pascal anglais : Drug susceptibility test, Identification, Rapid technique, Infection, Hospitalization, Care, Costs, Economic aspect, Mortality
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 94-0589541
Code Inist : 002B30A04B. Création : 09/06/1995.